Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: sickness (100), vomiting (348), unsettled stomach (2)

Fluorouracil RT Ver 1

Description: Chemotherapy Protocol COLORECTAL CANCER FLUOROURACIL-RADIOTHERAPY Regimen • Colorectal Cancer– Fluorouracil with concurrent radiotherapy Indication • Neoadjuvant treatment of rectal cancer. Tox
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Fluorouracil-RT.pdf

Crizotinib Ver 1

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CRIZOTINIB This protocol may require funding Regimen NSCLC - Cr
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CrizotinibVer1.pdf

Gemcitabine (21day) ver1.1

Description: Chemotherapy Protocol BLADDER GEMCITABINE (21 day) Regimen Bladder-Gemcitabine Indication Locally advanced or metastatic uroth
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Gemcitabine-21day-ver1.1.pdf

Docetaxel (30)-Prednisolone ver1.1

Description: Chemotherapy Protocol PROSTATE DOCETAXEL(30)-PREDNISOLONE Regimen Prostate-Docetaxel (30)-Prednisolone Indication Advanced castrate resistant
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Docetaxel-30-Prednisolone-ver1.1.pdf

Afatinib Ver 1

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Regimen AFATINIB NSCLC - Afatinib Indication Treatmen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/AfatinibVer1.pdf

Ibrutinib (WM) (420mg)

Description: Chemotherapy Protocol Waldenström's Macroglobulinaemia (WM) Regimen Ibrutinib • WM – Ibrutinib (420mg) Indication • The treatment of adult patients with Waldenström'
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Ibrutinib-WM-420mg.pdf

Chlorambucil Ver 1.1

Description: Chemotherapy Protocol LYMPHOMA CHLORAMBUCIL There are multiple versions of this protocol in use. Please ensure you have the correct protocol for the rele
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Chlorambucil-Ver-1.1.pdf

Cyclophosphamide Topotecan v1.1

Description: Chemotherapy Protocol SARCOMA CYCLOPHOSPHAMIDE-TOPOTECAN Regimen Sarcoma – Cyclophosphamide-Topotecan Indi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Cyclophosphamide-Topotecan-v1.1.pdf

Vemurafenib Ver 1

Description: Chemotherapy Protocol SKIN CANCER Regimen VEMURAFENIB Skin – Vemurafenib Indication Vemurafenib is recommended as an option for the treatment of BRAF mutation po
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinVemurafenibVer1.pdf

Dabrafenib Ver 1

Description: Chemotherapy Protocol SKIN CANCER DABRAFENIB Regimen Skin – Dabrafenib Indication Dabrafenib is recommended as an option for the first line treatment of unresectable BR
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibVer1.pdf

191 to 200 of 431

Previous … 18 19 20 21 22 … Next